Table 1.
Baseline characteristic of the RA patients and healthy controls.
| Variables | RA patients (n=50) | Healthy controls (n=30) | P value |
|---|---|---|---|
| Age(Years) | 35.90±18.607 | 34.03±10.3 | 0.7 |
| Gender(M/F) | 4/46 | 2/28 | 0.8 |
| Disease duration (Months) | 4.280±2.821 | - | - |
| BMI(kg/m2) | 36.15±9.400 | 34.90±13.51 | 0.4 |
| Anti CCP(RU/ml) | 215±164.1 | _ | _ |
| CRP(>0.3mg/l) | 21.14±15.89 | 0.23±0.14 | <0.0001 |
| VAS(0-100) | 58.54±19.78 | _ | _ |
| DAS 28-CRP | 5.175(4.303-5.715) | _ | _ |
| HAQ-DI | 2.559±0.94 | _ | _ |
Clinical and serological data of 50 early RA patients with synovitis and 30 individuals of healthy control. Data expressed as mean ± SD, median (interquartile range). BMI = basal metabolic rate. Anti-CCP = anti-citrullinated protein antibody; CRP = C-reactive protein; VAS = Visual Analogue Score; DAS 28-CRP = disease activity score 28 CRP; HAQ-DI = health assessment questionnaire disability index; p< 0.05 is considered significant.